Thorac Cardiovasc Surg 2007; 55(6): 380-384
DOI: 10.1055/s-2007-965196
Original Thoracic

© Georg Thieme Verlag KG Stuttgart · New York

Independent Predictors for Early and Midterm Mortality after Thoracic Surgery

T. Chamogeorgakis1 , C. E. Anagnostopoulos2 , C. P. Connery2 , R. C. Ashton2 , T. Dosios1 , G. Kostopanagiotou3 , C. K. Rokkas1 , I. K. Toumpoulis1
  • 1Department of Cardiothoracic Surgery, Attikon Hospital Center, Athens, Greece
  • 2Department of Cardiothoracic Surgery, Columbia University, St. Luke's - Roosevelt Hospital Center, New York, NY, USA
  • 3Department of Anesthesiology, Attikon Hospital Center, Athens, Greece
Further Information

Publication History

received Nov 10, 2006

Publication Date:
24 August 2007 (online)

Preview

Abstract

Background: The purpose of the present study was to determine independent predictors for early and midterm mortality for the whole context of thoracic surgery. Methods: We studied 1453 consecutive patients who underwent thoracic surgery between 2002 and 2005. Operations included lung resections (n = 504), mediastinal (n = 468), pleural and pericardial (n = 226), esophageal (n = 83), chest wall (n = 85), tracheal (n = 50) and other procedures (n = 37). Midterm survival data (mean follow-up 2.0 ± 1.1 years) were obtained from the National Death Index. Multivariate logistic regression was used to assess in-hospital mortality. Independent predictors for midterm mortality were determined by multivariate Cox regression analysis. Results: There were 47 (3.2 %) in-hospital and 312 (21.5 %) late deaths. Independent predictors for in-hospital mortality included Zubrod score (OR 2.72, p < 0.001), ASA score (OR 3.42, p < 0.001), pneumonectomy (OR 20.71, p = 0.001) and no history of cerebrovascular events (OR 0.27, p = 0.011). Independent predictors for midterm mortality included age (HR 1.03, p < 0.001), weight loss (HR 1.57, p = 0.005), Zubrod score (HR 1.47, p < 0.001), primary lung cancer (HR 1.98 p < 0.001), intrathoracic extrapulmonary metastases (HR 2.78, p < 0.001), primary chest wall tumor (HR 0.14, p = 0.008), diabetes requiring insulin (HR 1.71, p = 0.017), no preoperative renal failure (HR 0.57, p = 0.004), no comorbidities (HR 0.54, p = 0.009), ASA score (HR 1.69, p < 0.001), postoperative radiation treatment (HR 1.90, p = 0.016), pneumonectomy (HR 2.18, p = 0.040), reoperation for bleeding and/or postoperative transfusion (HR 3.10, p = 0.027) and postoperative pulmonary complications (HR 1.89, p = 0.013). Conclusions: We determined independent predictors for in-hospital and midterm mortality for the whole context of thoracic surgery. Zubrod and ASA scores affect both early and midterm mortality.

References

MD Themistocles Chamogeorgakis

Department of Cardiothoracic Surgery
Attikon Hospital Center

Sofokleous 36

16673 Voula

Greece

Phone: + 30 69 37 17 47 69

Fax: + 30 21 03 61 02 23

Email: thchamogeorgakis@yahoo.com